MetaCap

Acadia Healthcare (ACHC) vs Celcuity (CELC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Acadia Healthcare (ACHC) has outperformed Celcuity (CELC) over the past year, gaining 127.9% versus a loss of 45.3%. Over five years, CELC leads with a +249.6% price change compared with -40.1% for ACHC. Acadia Healthcare is the larger company by market cap ($3.22 billion vs $2.61 billion), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ACHC+127.93%CELC-45.28%
+166%+55%-55%
Nov 21, 20251 yearNov 20, 2026
ACHC-44.12%CELC+231.99%
+802%+340%-123%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ACHC versus CELC key metrics
MetricACHCCELC
Share price$34.60$53.35
Market cap$3.22B$2.61B
1-day change+0.38%-5.26%
YTD return+143.83%-46.51%
1-year return+127.93%-45.28%
5-year return-40.15%+249.61%
Forward P/E17.07—
EPS (TTM)$-12.44$-4.72
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$3.31B—
Revenue growth (YoY)+5.04%—
Net income (latest FY)$-1.10B$-177.04M
Net margin-33.29%—
52-week high$39.70$151.02
52-week low$11.43$53.20
Distance from 52-week high-12.85%-64.67%
Analyst consensusbuystrong_buy
Avg. price target upside+12.92%+182.76%
Average volume1.84M1.25M
Shares outstanding92.97M48.93M
Employees19,000155
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ACHC has outperformed CELC by 173.2 percentage points over the past year.

About Acadia Healthcare

ACHC stock →

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico.

Health Care · Medical Specialities · 19,000 employees

About Celcuity

CELC stock →

Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC).

Health Care · Medical Specialities · 155 employees

ACHC vs CELC FAQ

Which is bigger, Acadia Healthcare or Celcuity?

Acadia Healthcare (ACHC) is larger, with a market capitalization of $3.22B compared with $2.61B for Celcuity (CELC).

Which stock has performed better over the past year, ACHC or CELC?

ACHC returned +127.93% over the past 12 months, compared with -45.28% for CELC (price return, excluding dividends). Past performance does not predict future results.

Are Acadia Healthcare and Celcuity in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons